Medicine
fromScienceDaily
10 hours agoNew "Trojan horse" obesity drug supercharges weight loss in early tests
Researchers developed a hybrid obesity drug using GLP-1/GIP signals as a delivery mechanism to target metabolic enhancers directly into cells, achieving superior weight loss and blood sugar control in mice at lower doses.